Statera Biopharma eyes worst day in nearly a year on $2 mln equity sale

Statera Biopharma

07/02/2022 13:52

** Immune therapy developer Statera Biopharma's shares
 STAB.O  plunge 26% to 97 cents premarket, set for biggest pct
fall in nearly a year
    ** STAB to sell about 2 mln of its common stock and warrants
for another ~2 million shares to an institutional investor
 urn:newsml:reuters.com:*:nGNXrhrq7
    ** Price of 1 share and 1 warrant to be $1, with co grossing
about $2 million in proceeds
    ** STAB has 22.6 million shares in free float - Refinitiv
IBES data
    ** Up to Friday's close, stock had fallen 43% YTD and
slumped by a third in 2021

 (Reporting by Leroy Leo)
 ((Leroy.Dsouza@thomsonreuters.com;))